R1 Therapeutics

Series-A
r1therapeutics.com Biotech & Healthcare London, United Kingdom Founded 2024 1-10
Total Funding $158M
Latest Round $80.5M Series-A
Last Announced Sep 30, 2026
Investors 7 Backers
Decision Makers 6 Verified

About R1 Therapeutics

R1 Therapeutics is a clinical-stage biopharmaceutical company that develops first-in-class treatments for kidney disease patients.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters London, United Kingdom
Year Founded 2024
Team Size 1-10
Tracked Since Oct 4, 2026

Web & Domain Identity

Official Website r1therapeutics.com
Domain Registered Date Sep 22, 2025

Social & Network Presence

X / Twitter Profile @companies
LinkedIn Corporate Company Profile

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $80,500,000 · Series-A

    Backed by Samsara Biocapital

  2. Capital Raise

    Raised $77,500,000 · Series-A

    Backed by Abingworth, DaVita Venture Group

  3. Milestone

    Website domain registered

    r1therapeutics.com

  4. Milestone

    Company founded

    London, United Kingdom

Investors & Backers

7
Abingworth
Curie.Bio
DaVita Venture Group
F-Prime Capital
Samsara Biocapital
SymBiosis
U.S. Renal Care

Funding History

2 Rounds
Series-A equity · Sep 30, 2026

Round backers: Samsara Biocapital

Series-A equity · Mar 17, 2026

Round backers: Abingworth, DaVita Venture Group, F-Prime Capital, Curie.Bio, SymBiosis, U.S. Renal Care

$77,500,000 pharmiweb.com

Founders & Leadership

2

Krishna Polu

Founder

Work email & phone locked Unlock →

L. Mary Smith

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts